ArticleInterdisciplinary sciences, computational life sciences2026
A Scalable and Robust Ensemble Deep Learning Method for Predicting Drug-Target Interactions.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate identification of drug-target interactions (DTIs) is a crucial step in drug discovery. Computational DTI prediction methods can significantly reduce the time and cost associated with drug development. However, effectively integrating multisource features for high-precision DTI prediction remains a challenge. In this study, we propose EDeepDTI, an ensemble deep learning framework designed to increase the accuracy and generalizability of DTI predictions by efficiently integrating multi-view features. EDeepDTI calculates multiple molecular fingerprints to extract rich substructural information from drugs, leverages several advanced pre-trained models to generate drug and protein features enriched with structural and semantic information, and calculates multiple semantic similarity features for drugs and proteins using various similarity measures. During the ensemble learning process, we design a deep learning base learner for each unique pairing of drug and protein features. This ensures that each base learner captures distinct feature interactions, enhancing both independence and diversity within the ensemble. Finally, a greedy strategy is employed to aggregate the predictions from all base learners to improve overall performance. The experimental results demonstrate that EDeepDTI and its variant consistently outperform the baseline methods across multiple datasets and prediction tasks, highlighting the superior performance, robustness, and scalability of EDeepDTI.
Indexed as
Identifiers
41120647What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.